Condition: Primary Sjogren's Disease · Sponsor: Vor Biopharma
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)
This description comes directly from the study's public registry record.
Jeremy Sokolove · 6176556580 · Study@vorbio.com
Always discuss trial participation with your own doctor first.
| Arizona Arthritis & Rheumatology Associates P.C. | Chandler, Arizona, United States | Recruiting |
| Arizona Arthritis & Rheumatology Associates P.C. | Flagstaff, Arizona, United States | Recruiting |
| Arizona Arthritis & Rheumatology Associates, PLLC | Glendale, Arizona, United States | Recruiting |
| Arizona Arthritis & Rheumatology Associates P.C. | Phoenix, Arizona, United States | Recruiting |
| Arizona Arthritis & Rheumatology Associates, P.C. | Tucson, Arizona, United States | Recruiting |
| Wallace Rheumatic Study Center | Beverly Hills, California, United States | Recruiting |
| Denver Arthritis Clinic | Denver, Colorado, United States | Recruiting |
| Clinical Research of West Florida, Inc. | Clearwater, Florida, United States | Recruiting |
| Finlay Medical Research Corp | Green Acres, Florida, United States | Recruiting |
| Suncoast Clinical Research Inc. | New Port Richey, Florida, United States | Recruiting |
| Bioresearch Partner | South Miami, Florida, United States | Recruiting |
| Chicago Clinical Research Institute Inc | Chicago, Illinois, United States | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07404865